Stocks
Axsome Therapeutics (AXSM) Operating Income US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -99.1 | -124.7 | -179.8 | -176.5 | -231.8 | -307.5 | |||
| Changes by years, y/y, % | +47% | +26% | +44% | -2% | +31% | +47.8% | |||
Axsome Therapeutics. Operating Income, bln rub
Axsome Therapeutics. Operating Income, changes, %
Axsome Therapeutics. Operating Income, sum by quarters, bln rub
Axsome Therapeutics (AXSM) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | -62.1 | -98.1 | -68.7 | -78.0 | -62.6 | -307.5 | ||
| Changes by years, y/y, % | +46% | +76% | +951% | +20% | +1% | |||
| Changes by quarters, q/q, % | -5% | +58% | -30% | +14% | -20% | |||
